Suppr超能文献

印度南部糖尿病的医疗保健成本:一项疾病成本研究。

Health-care cost of diabetes in South India: A cost of illness study.

作者信息

Akari Sadanandam, Mateti Uday Venkat, Kunduru Buchi Reddy

机构信息

Department of Pharmacy Practice and Pharm D, St. Peter's Institute of Pharmaceutical Sciences, Rohini Super Specialty Hospital, Kakatiya University, Warangal, Andhra Pradesh, India.

Department of Pharmacy Practice and Pharm D, St. Peter's Institute of Pharmaceutical Sciences, Rohini Super Specialty Hospital, Kakatiya University, Warangal, Andhra Pradesh, India ; Department of Pharmacy Management, Manipal University, Manipal, Karnataka, India.

出版信息

J Res Pharm Pract. 2013 Jul;2(3):114-7. doi: 10.4103/2279-042X.122382.

Abstract

OBJECTIVE

The objective of this study is to analyze the health-care cost by calculating the direct and indirect costs of diabetes with co-morbidities in south India.

METHODS

A prospective observational study was conducted at Rohini super specialty hospital (India). Patient data as well as cost details were collected from the patients for a period of 6 months. The study was approved by the hospital committee prior to the study. The diabetic patients of age >18 years, either gender were included in the study. The collected data was analyzed for the average cost incurred in treating the diabetic patients and was calculated based on the total amount spent by the patients to that of total number of patients.

FINDINGS

A total of 150 patients were enrolled during the study period. The average costs per diabetic patient with and without co-morbidities were found to be United States dollar (USD) 314.15 and USD 29.91, respectively. The average cost for those with diabetic complications was USD 125.01 for macrovascular complications, USD 90.43 for microvascular complications and USD 142.01 for other infections. Out of USD 314.15, the average total direct medical cost was USD 290.04, the average direct non-medical cost was USD 3.75 and the average total indirect cost was USD 20.34.

CONCLUSION

Our study results revealed that more economic burden was found in male patients (USD 332.06), age group of 51-60 years (USD 353.55) and the patients bearing macrovascular complications (USD 142.01). This information can be a model for future studies of economic evaluations and outcomes research.

摘要

目的

本研究的目的是通过计算印度南部患有合并症的糖尿病患者的直接和间接成本来分析医疗保健成本。

方法

在罗希尼超级专科医院(印度)进行了一项前瞻性观察研究。收集了患者6个月期间的患者数据以及成本细节。该研究在开展前获得了医院委员会的批准。年龄大于18岁的糖尿病患者,无论性别,均纳入研究。对收集到的数据进行分析,以确定治疗糖尿病患者的平均成本,并根据患者的总支出与患者总数来计算。

研究结果

在研究期间共招募了150名患者。发现患有合并症和未患有合并症的糖尿病患者的平均成本分别为314.15美元和29.91美元。患有糖尿病并发症的患者中,大血管并发症的平均成本为125.01美元,微血管并发症为90.43美元,其他感染为142.01美元。在314.15美元中,平均总直接医疗成本为290.04美元,平均直接非医疗成本为3.75美元,平均总间接成本为20.34美元。

结论

我们的研究结果显示,男性患者(332.06美元)、51 - 60岁年龄组(353.55美元)以及患有大血管并发症的患者(142.01美元)的经济负担更重。这些信息可作为未来经济评估和结果研究的模型。

相似文献

1
Health-care cost of diabetes in South India: A cost of illness study.
J Res Pharm Pract. 2013 Jul;2(3):114-7. doi: 10.4103/2279-042X.122382.
4
The Economic Burden of Type 2 Diabetes Mellitus in Pakistan: A Cost of Illness Study.
Healthcare (Basel). 2024 Sep 12;12(18):1826. doi: 10.3390/healthcare12181826.
5
Economic Burden of Mental Illnesses in Pakistan.
J Ment Health Policy Econ. 2016 Sep;19(3):155-66.
6
Cost of treatment for head and neck cancer in India.
PLoS One. 2018 Jan 11;13(1):e0191132. doi: 10.1371/journal.pone.0191132. eCollection 2018.
7
Cost of diabetes and its complications in Thailand: a complete picture of economic burden.
Health Soc Care Community. 2011 May;19(3):289-98. doi: 10.1111/j.1365-2524.2010.00981.x. Epub 2011 Jan 29.
8
Cost of Illness Analysis of Type 2 Diabetes Mellitus: The Findings from a Lower-Middle Income Country.
Int J Environ Res Public Health. 2022 Oct 2;19(19):12611. doi: 10.3390/ijerph191912611.
9
Healthcare costs and resource utilization in patients with severe aplastic anemia in the US.
J Med Econ. 2019 Oct;22(10):1055-1062. doi: 10.1080/13696998.2019.1643354. Epub 2019 Aug 4.
10

引用本文的文献

1
Cost of type 2 diabetes mellitus management for households in Northern India - an econometric analysis.
BMC Health Serv Res. 2025 Jul 22;25(1):965. doi: 10.1186/s12913-025-13040-w.
3
Cost of diabetes mellitus and associated factors - an institutional cross-sectional study in Ghana.
BMC Health Serv Res. 2025 Apr 8;25(1):514. doi: 10.1186/s12913-025-12667-z.
4
A systematic review of the economic burden of diabetes mellitus: contrasting perspectives from high and low middle-income countries.
J Pharm Policy Pract. 2024 Apr 19;17(1):2322107. doi: 10.1080/20523211.2024.2322107. eCollection 2024.
6
Estimating the Health Care Expenditure to Manage and Care for Type 2 Diabetes in Nepal: A Patient Perspective.
MDM Policy Pract. 2023 Dec 14;8(2):23814683231216938. doi: 10.1177/23814683231216938. eCollection 2023 Jul-Dec.
7
A Strategic Research Framework for Defeating Diabetes in India: A 21st-Century Agenda.
J Indian Inst Sci. 2023 Mar 21:1-22. doi: 10.1007/s41745-022-00354-5.
8
Cost of diabetes and its complications: results from a STEPS survey in Punjab, India.
Glob Health Res Policy. 2023 Apr 7;8(1):11. doi: 10.1186/s41256-023-00293-3.
9
Health care utilization and out-of-pocket expenditure of type 2 diabetic patients: A study in primary care in Bhubaneswar, India.
J Family Med Prim Care. 2022 Nov;11(11):6714-6725. doi: 10.4103/jfmpc.jfmpc_1305_21. Epub 2022 Dec 16.
10
Gestational diabetes in rural central India: low prevalence but absence of typical risk factors.
Heliyon. 2021 Jun 28;7(7):e07431. doi: 10.1016/j.heliyon.2021.e07431. eCollection 2021 Jul.

本文引用的文献

2
Global healthcare expenditure on diabetes for 2010 and 2030.
Diabetes Res Clin Pract. 2010 Mar;87(3):293-301. doi: 10.1016/j.diabres.2010.01.026. Epub 2010 Feb 19.
3
Economic analysis of diabetes care.
Indian J Med Res. 2007 Mar;125(3):473-82.
4
Economic cost associated with type II diabetes in Spanish patients.
Eur J Health Econ. 2006 Dec;7(4):270-5. doi: 10.1007/s10198-006-0367-9.
5
Economic costs of diabetes in the US in 2002.
Diabetes Care. 2003 Mar;26(3):917-32. doi: 10.2337/diacare.26.3.917.
6
7
Direct medical costs for patients with type 2 diabetes in Sweden.
J Intern Med. 2000 Nov;248(5):387-96. doi: 10.1046/j.1365-2796.2000.00749.x.
8
Rising prevalence of NIDDM in an urban population in India.
Diabetologia. 1997 Feb;40(2):232-7. doi: 10.1007/s001250050668.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验